European Parliament - SANT Subcommittee (Public Health) · July 16, 2026

European Biotech Act: amendments 2522–2801 to draft report on strengthening biotechnology and biomanufacturing sectors

Original title: AMENDMENTS 2522 - 2801 - Draft report Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) - PE790.939v01-00

Parliamentary amendments to proposed European Biotech Act framework amending regulations on food safety, advanced therapies, clinical trials, veterinary medicines, and biomanufacturing.

Medium impact Pharmaceuticals Medical Devices & IVD Clinical Trials & Research EU-wide pharmaceuticalsclinical-trialsivdmedical-devices

AMENDMENTS 2522 - 2801 - Draft report Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act)<br />Committee on Industry, Research and Energy<br />Committee on Public Health<br />Wouter Beke, Vytenis Povilas Andriukaitis<br /> <br />Source : <a href="https://www.europarl.europa.eu/privacy-policy/en">© European Union, 2026 - EP</a>

Read the official source ↗

Published by European Parliament - SANT Subcommittee (Public Health). HealthSignal links to the original document; the summary above is extracted from the source text.